Rocklatan® Evaluation
Public ClinicalTrials.gov record NCT05283395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label Rocklatan® (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% Evaluation of IOP Lowering Efficacy and Safety as Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the IOP-lowering effect when subjects are switched from various latanoprost-based regimens to Rocklatan. Subjects will stop their IOP-lowering medical therapy regimen and dose with Rocklatan for the duration of the study (12 weeks).
Study identification
- NCT ID
- NCT05283395
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 28, 2022 (Actual)
- Primary completion
- Mar 22, 2023 (Actual)
- Completion
- Mar 22, 2023 (Actual)
- Last update posted
- Apr 3, 2024
2022 – 2023
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| North Valley Eye Medical Group | Mission Hills | California | 91345 | — |
| Visionary Eye Institute | Newport Beach | California | 92663 | — |
| California Eye Specialists Medical Group | Pasadena | California | 91107 | — |
| North Bay Eye Associates | Petaluma | California | 94954 | — |
| Shettle Eye Research | Largo | Florida | 33773 | — |
| Center For Sight | Venice | Florida | 34285 | — |
| Georgia Eye Partners | Atlanta | Georgia | 30342 | — |
| Coastal Research Associates LLC | Roswell | Georgia | 30076 | — |
| Tekwani Vision Center | St Louis | Missouri | 63128 | — |
| OCLI Vision | Manhasset | New York | 11030 | — |
| Mark J. Weiss, MD, Inc. | Tulsa | Oklahoma | 74104 | — |
| Scott & Christie and Associates, PC | Cranberry Township | Pennsylvania | 16066 | — |
| Advancing Vision Research | Goodlettsville | Tennessee | 37072 | — |
| VRF Eye Specialty Group | Memphis | Tennessee | 38120 | — |
| Total Eye Care, PA | Memphis | Tennessee | 38199 | — |
| Keystone Research | Austin | Texas | 78731 | — |
| Louis M. Alpern, M.D., M.P.H., P.A | El Paso | Texas | 79902 | — |
| Houston Eye Associates | Houston | Texas | 77025 | — |
| Emerson Clinical Research Institute | Falls Church | Virginia | 22046 | — |
| Vistar Eye Center | Roanoke | Virginia | 24016 | — |
| The Eye Centers of Racine and Kenosha | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05283395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2024 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05283395 live on ClinicalTrials.gov.